U.S. Markets open in 6 hrs 23 mins

AcelRx Pharmaceuticals, Inc. (ACRX)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
3.200.00 (0.00%)
At close: 4:00PM EDT
People also watch
AVEOALIMVSTMFOLDSGYP
Full screen
Previous Close3.20
Open3.25
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.20 - 3.30
52 Week Range1.95 - 4.08
Volume1,168,358
Avg. Volume1,303,479
Market Cap145.22M
Beta3.13
PE Ratio (TTM)-2.92
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube9 days ago

    ETFs with exposure to AcelRx Pharmaceuticals, Inc. : September 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AcelRx Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACRX-US. Comparing the performance and risk of AcelRx Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube20 days ago

    ETFs with exposure to AcelRx Pharmaceuticals, Inc. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AcelRx Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACRX-US. Comparing the performance and risk of AcelRx Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • AcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube27 days ago

    AcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis AcelRx Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of AcelRx Pharmaceuticals, Inc. – Pain Therapeutics, Inc., BioDelivery Sciences International, Inc., DURECT Corporation, Insys Therapeutics, Inc., Galena Biopharma, Inc., Cara Therapeutics Inc and Medicines Company (PTIE-US, BDSI-US, DRRX-US, ... Read more (Read more...)